More mouth bacteria diversity tied to worse IPF lung function: Study

My strategy to weather the storm of constant lung infections

Recurrent lung infections are exhausting, both physically and mentally. As a patient living with idiopathic pulmonary fibrosis (IPF), a progressive and life-threatening lung disease, respiratory infections have become part of my life. But that doesn’t mean they’re easy to deal with. When I read a fellow columnist’s recent post…

Acute flares before lung transplant put ILD patients at higher risk

Acute exacerbations, or sudden bouts of symptom worsening, increase the mortality risk after lung transplantation in people with interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF), a study reports. While a lung transplant is considered an effective treatment for ILDs, these findings “suggest that caution is required during decision-making,…

Nippon awarded exclusive rights in Japan to IPF treatment C21

Sweden-based Vicore Pharma has granted exclusive rights to pharmaceutical company Nippon Shinyaku to develop and commercialize its treatment candidate C21 (VP01) in Japan, with an initial focus on idiopathic pulmonary fibrosis (IPF). Nippon will be operationally and financially responsible for the development of C21 in Japan, where…

5 PFF Scholars each awarded $100K in research grants

Five new Pulmonary Fibrosis Foundation (PFF) scholars will each use $100,000, granted over the course of two years, to research new ways to diagnose, treat, or manage pulmonary fibrosis (PF). The six-year-old program awards grants each year to help scientists improve their understanding of PF, a chronic…

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums